Content
All Posts > Content under Pharma/Biotech
The Stock Market Stands On A Precarious Scaffold
Article By:
Michele Schneider
Read
Sunday, September 1, 2019 10:15 AM EDT
In the current market, the price action and negative phases in the indices hang precariously. The bulls, nevertheless, continue to trust the scaffolding of low interest rates, hope for a resolution of tariffs and positive economic statistics.
Week In Review: HiFiBiO Raises $67 Million For Immune Modulator Portfolio
Article By:
ChinaBio® Today
Read
Saturday, August 31, 2019 4:14 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Week In Review: Biotheus Acquires China Rights To Three Bi-specifics In $142 Million Deal
Article By:
ChinaBio® Today
Read
Saturday, August 24, 2019 5:15 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Stock Charts To Watch - August 19, 2019
Video By:
Harry Boxer
Watch
Monday, August 19, 2019 5:14 PM EDT
Amyris, Inc. had a really good session on Monday, jumping 74 cents, or 20%, to 4.41, on 1.5 million shares. Arrowhead Pharmaceuticals, Neogen Corp., Perion Network, SunPower Corp., and XPO Logistics look good as well. Let's take a closer look
Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
Article By:
ChinaBio® Today
Read
Saturday, August 17, 2019 4:06 PM EDT
China's Chipscreen Bio traded 367% higher following its $148 million IPO on the Shanghai STAR exchange, raising its market cap to $4.2 billion.
Cannabis Central: Canopy Growth Reports Q1 Revenue Up 249% But Net Loss Up 1,308% - Stock Tanks
Article By:
Lorimer Wilson
Read
Friday, August 16, 2019 7:59 AM EDT
Canopy Growth Q1 Corp. announced its Q1 financial results for the first quarter on Wednesday but the market did not take kindly to what it reported. The stock has dropped 20% in the last 2 days (-14% on Thursday alone).
In this article: CGC
Cannabis Central: Tilray, Inc. Reports Major Q2 Net Loss - Stock Drops More Than 20%
Article By:
Lorimer Wilson
Read
Thursday, August 15, 2019 4:12 PM EDT
Shares of Tilray, Inc. (TLRY) dropped 15% on Wednesday after reporting a net loss of US$35.1M for Q2 and fell another 10% today.
In this article: TLRY
Bull Of The Day: GW Pharmaceuticals (GWPH)
Article By:
Kevin Cook
Read
Thursday, August 15, 2019 6:20 AM EDT
GWPH crushed the sales number for the treatment of two rare forms of pediatric epilepsy with $68 million vs. consensus of $45M.
In this article: GWPH
Cannabis Central: Only 2 ETFs Provide Exclusive Exposure To U.S. Marijuana Multi-State Operators
Article By:
Lorimer Wilson
Read
Monday, August 12, 2019 11:27 AM EDT
Marijuana cultivation is legal in 33 American states but remains federally illegal so U.S. companies in the business can't list their securities on U.S. stock exchanges so many such companies are listing their stocks on Canadian stock exchanges.
Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma
Article By:
ChinaBio® Today
Read
Saturday, August 10, 2019 6:05 PM EDT
Nanjing King-Friend Bio invested $95 million in Meitheal Pharma of Chicago, a generic injectables company, raising its holdings to a majority stake.
In this article: GILD
Cannabis Central: These Marijuana- Related Companies Pay Dividends
Article By:
Lorimer Wilson
Read
Friday, August 9, 2019 3:44 AM EDT
Several consumer goods & biopharmaceutical companies have ventured into the marijuana space but continue to generate the majority of their revenues and earnings in their primary business.
In this article: CODI, MO, ABBV, ACNFF, IMBBY, NVS, TAP, BUD, SMG, STZ, IIPR, ASBFY Also: CRON, HEXO, TLRY
